# Centaur Pharmaceuticals Private Ltd. – FDA Inspection, May 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/b8ac7385-a0ad-4590-a0d8-af7b5ccb1332
Source feed: FDA_Inspections

> FDA inspection 1092125 of Centaur Pharmaceuticals Private Ltd., May 13, 2019. Classification: No Action Indicated (NAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1092125
- Company Name: Centaur Pharmaceuticals Private Ltd.
- Inspection Date: 2019-05-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1333532 - 2026-08-24](https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/32bda89b-a59e-4c39-b1e2-190ead46a448)
- [FDA Inspection 1198364 - 2023-02-08](https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/2e11e9b3-3ae0-4157-8a97-9c1f32c046ba)
- [FDA Inspection 1002848 - 2016-11-14](https://www.keypedia.com/records/fda_inspections/centaur-pharmaceuticals-private-ltd/7225abfc-7514-43fd-8130-95b98243d995)
- FDA Inspection 871580 - 2014-03-27
- FDA Inspection 740704 - 2011-08-19

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/jose-f-velez/0d1951e8-3aa5-48ff-bc54-1fae8a7a57c9)

Company: https://www.keypedia.com/companies/centaur-pharmaceuticals-private-ltd/65d235da-0400-49d7-acff-38fe013fc5b4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
